Company Overview

Earth Science Tech, Inc. (OTC Pink: ETST) is a U.S.-based holding company focused on health, wellness, nutrition, and biotechnology-related consumer products. The company has historically operated in the cannabidiol (CBD), hemp-derived wellness, and nutraceutical sectors, while also expanding into pharmaceutical distribution and telemedicine-related healthcare services through acquisitions and subsidiaries. Public filings and corporate disclosures indicate that ETST’s business model has evolved from direct CBD product sales into a broader healthcare and life sciences platform.

The company’s primary revenue drivers have included pharmaceutical distribution, nutritional supplements, wellness products, and healthcare-related services operated through affiliated entities. ETST has pursued growth through acquisitions and subsidiary expansion rather than large-scale internal manufacturing. Its positioning has centered on participation in regulated healthcare distribution and wellness markets, particularly in the United States and parts of Latin America. The company was founded in 2010 and later reoriented toward hemp-derived products before shifting strategic emphasis toward healthcare services, pharmaceuticals, and medical distribution activities through subsequent corporate transactions.

Business Operations

ETST conducts operations through subsidiaries and affiliated healthcare businesses. Public disclosures identify activities connected to pharmaceutical distribution, telemedicine infrastructure, medical clinic operations, and wellness products. The company has referenced operations involving RxCompoundStore.com, Earth Science Foundation, and healthcare-focused subsidiaries tied to pharmaceutical logistics and patient services. Revenue generation has primarily come from product sales, healthcare distribution arrangements, and related service operations.

The company’s operational footprint has included both domestic and international activities. In the United States, ETST has focused on healthcare distribution and wellness-oriented products, while certain acquisitions and partnerships have expanded exposure to Latin American markets, including pharmaceutical and medical supply distribution opportunities. Available filings indicate that ETST relies heavily on acquisitions, licensing relationships, and strategic partnerships rather than vertically integrated manufacturing assets. Some operational claims regarding scale and commercial reach vary across company communications, and certain details remain difficult to independently verify through public filings alone.

Strategic Position & Investments

ETST’s strategic direction has emphasized expansion into healthcare infrastructure, pharmaceutical distribution, and technology-enabled medical services. The company has pursued acquisitions intended to diversify revenue away from commodity CBD products and toward regulated healthcare markets with recurring demand characteristics. Public announcements and filings have referenced investments in pharmaceutical logistics, telehealth capabilities, and medical product distribution networks.

The company has also highlighted ownership or control interests in healthcare-oriented subsidiaries and affiliated businesses, including entities tied to prescription fulfillment and medical distribution. ETST’s acquisition strategy has targeted businesses positioned in healthcare supply chains and wellness markets, particularly where cross-border distribution opportunities may exist. While management has presented these initiatives as long-term growth drivers, some announced transactions and operational milestones have limited publicly available financial detail beyond company disclosures. Data inconclusive based on available public sources regarding the full financial contribution of certain subsidiaries and partnerships.

Geographic Footprint

ETST is headquartered in the United States, with operations and commercial activities primarily centered in the domestic healthcare and wellness markets. The company’s historical filings and investor materials indicate business activity across multiple U.S. states through subsidiaries, distribution arrangements, and healthcare-related operations.

Internationally, ETST has referenced commercial relationships and expansion initiatives in Latin America, particularly involving pharmaceutical distribution and medical supply opportunities. The company has also indicated interest in broader international healthcare markets through strategic partnerships and acquisition activity. However, independently verified details regarding the scale of international operations remain limited compared with disclosures available for domestic activities.

Leadership & Governance

ETST has undergone multiple leadership transitions as the company evolved from a hemp and wellness business into a broader healthcare-focused holding company. Corporate governance and strategic direction have centered on acquisition-led expansion and diversification into regulated healthcare sectors. Management communications have emphasized building an integrated healthcare and pharmaceutical distribution platform while pursuing growth through subsidiary development and strategic partnerships.

Key executives and leaders identified in public filings and company disclosures include:

• Giorgio R. Saumat – Former Chief Executive Officer
• Mister Medrano – Chief Executive Officer (reported in later company disclosures)
• Francisco Antonio Diaz – Executive associated with healthcare and pharmaceutical operations
• Rodrigo Monteverde – Executive affiliated with international business development initiatives

Leadership structure and executive roles have changed periodically, and certain appointments reported in company announcements are not consistently reflected across all publicly available filings. Data inconclusive based on available public sources regarding the current composition of all executive leadership positions.